July 23, 2012
Masayoshi Toyoura, president of Hiroshima Bio-Medical Co., Ltd. (HBM; http://www.hiroshima-bm.com ), outlined his company’s business policy and plans at a recent monthly meeting of the Japan Pharmaceutical Licensing Association (JPLA) in Tokyo, stressing that HBM is committed to building up...read more